Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Benylin Herbal Chesty Coughs Sugar Free Syrup

Active Ingredient:
ivy leaf dry extract
Company:  
McNeil Products Ltd See contact details
About Medicine
{healthcare_pro_orange} This information is for use by healthcare professionals
Last updated on emc: 01 Sep 2022
1. Name of the medicinal product

Benylin Herbal Chesty Coughs Sugar Free Syrup

2. Qualitative and quantitative composition

4 ml of syrup contains 33 mg of extract (as dry extract) of Ivy leaf (Hedera helix L.) (DER 4-8:1)

Extraction solvent: Ethanol 30% m/m

Each 4ml of syrup contains 2832 mg of Sorbitol (See 'Section 4.4 Special warnings and precautions for use')

For the full list of excipients, see section 6.1.

3. Pharmaceutical form

Syrup

Brown, opalescent liquid with a sweet taste.

4. Clinical particulars
4.1 Therapeutic indications

Benylin Herbal Chesty Coughs Sugar Free Syrup is a traditional herbal medicinal product used to relieve chesty coughs associated with the common cold, based on traditional use only.

4.2 Posology and method of administration

Posology

Adults, the elderly, and children aged 12 years and over

The recommended dose is 4 ml of syrup two to three times daily using the graduated measuring spoon provided

The use in children under 12 years of age is not recommended (see section 4.4 Special warnings and precautions for use).

Method of administration

For oral use only.

Shake the bottle well before each use.

If the symptoms worsen, or persist longer than one week during the use of Benylin Herbal Chesty Coughs Sugar Free Syrup, a doctor or qualified healthcare practitioner should be consulted.

The product should not be used for more than 2 weeks.

4.3 Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

4.4 Special warnings and precautions for use

Do not exceed the stated dose.

The use of this product in children under 12 years of age is not recommended because data are not sufficient and medical advice should be sought.

If dyspnoea, fever or purulent sputum occurs, a doctor should be consulted.

If the symptoms worsen, or persist longer than one week during the use of Benylin Herbal Chesty Coughs Sugar Free Syrup, a doctor or qualified healthcare practitioner should be consulted.

Concomitant use with antitussives such as codeine or dextromethorphan is not recommended without medical advice.

Caution is recommended in patients with gastritis or gastric ulcer.

Benylin Herbal Chesty Coughs Sugar Free Syrup contains sorbitol.

The additive effect of concomitantly administered products containing sorbitol (or fructose) and dietary intake of sorbitol (or fructose) should be taken into account. The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly. Each 4 ml of syrup contains 2832 mg of sorbitol (E 420).

Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product.

Sorbitol may cause gastrointestinal discomfort and mild laxative effect.

4.5 Interaction with other medicinal products and other forms of interaction

None reported

4.6 Fertility, pregnancy and lactation

Safety during pregnancy and lactation has not been established. In the absence of sufficient data, the use during pregnancy and lactation is not recommended.

Fertility

No studies on the effect on fertility have been performed.

4.7 Effects on ability to drive and use machines

No studies on the effect on the ability to drive and use machines have been performed.

4.8 Undesirable effects

Gastrointestinal reactions (nausea, vomiting, and diarrhoea) have been reported. The frequency is not known.

Allergic reactions (urticaria, skin rash, dyspnoea) have been reported. The frequency is not known.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9 Overdose

Overdose can provoke nausea, vomiting, diarrhoea and agitation.

One case of a 4-year old child who developed aggressivity and diarrhoea after accidental intake of an ivy extract corresponding to 1.8 g herbal substance has been reported.

5. Pharmacological properties
5.1 Pharmacodynamic properties

Not required as per Article 16c(1)(a)(iii) of Directive 2001/83/EC as amended.

5.2 Pharmacokinetic properties

Not required as per Article 16c(1)(a)(iii) of Directive 2001/83/EC as amended.

5.3 Preclinical safety data

Reverse mutation assays (Ames test) on bacteria indicated that the herbal preparation was not mutagenic in Salmonella typhimurium (strains TA 98, TA 100, TA 1535 and TA 1537) mutation assays with or without metabolic activation

Adequate tests on reproductive toxicity and carcinogenicity have not been performed.

6. Pharmaceutical particulars
6.1 List of excipients

Sorbitol, liquid (non-crystallising) (E 420)

Xanthan gum

Potassium sorbate

Citric acid, anhydrous

Purified water

6.2 Incompatibilities

Not applicable.

6.3 Shelf life

Unopened: 3 years.

Opened: 3 months.

6.4 Special precautions for storage

This medicinal product does not require any special storage conditions.

After first opening do not store above 25 ° C.

6.5 Nature and contents of container

This medicinal product is available in 100 ml bottles made of brown glass. The bottles are closed with white screw caps (HDPE) with cone sealing.

The bottle is further packed into cartons together with a measuring spoon (with graduation 2 and 4 ml).

6.6 Special precautions for disposal and other handling

No special requirements.

7. Marketing authorisation holder

McNeil Products Limited,

50 – 100 Holmers Farm Way

High Wycombe

Buckinghamshire

HP12 4EG

UK

8. Marketing authorisation number(s)

THR 15513/0185

9. Date of first authorisation/renewal of the authorisation

25 April 2019

10. Date of revision of the text

14 April 2022

McNeil Products Ltd
Company image
Address
50-100 Holmers Farm Way, High Wycombe, HP12 4EG, UK
Medical Information Direct Line
0808 238 9999 (freephone)
Medical Information e-mail
[email protected]